(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CUREVO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CUREVO

ST13

US500000079221428

Class

5, 35

Filing

79221428

Registration

5619567

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

47

Latest update

08/06/2026

Trademark type

Word

Nice classes

5, 35

Filing date

09/29/2017

Registration date

12/04/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/26/2025

Last transaction

08/06/2026

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

Bothell, US

Examiner

BILLINGS, JOHN T

Current location

Historical data usage

Holders and representatives

Holders

Curevo Inc.
GREEN CROSS HOLDINGS CORPORATION

Representatives

Brendan J. Hughes Cooley LLP

Technical classification

Nice Classes

Class 5Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical agents affecting sensory organs; Thyroid and para-thyroid hormone preparations; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for treating diabetes; Pharmaceutical agents affecting metabolism; Vaccines against flu; veterinary vaccines; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for regulating the immune system; Virucides; Vaccine preparations ; Adrenal hormone preparations; Pharmaceutical preparations and substances for use in gynecology; Pharmaceutical preparations for use in urology; Vitamin tablets; Pharmaceutical preparations for wounds; Pharmaceutical preparations for activating cellular function; Anti-inflammatory preparations; Pharmaceutical agents affecting digestive organs; Reagents for use in veterinary genetic testing; Pharmaceutical preparations for the treatment of cardiovascular disease; Ophthalmic preparations; Ophthalmologic preparations; Eye drops; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations and substances for the prevention of cancer; Biological preparations for the treatment of cancer; Pharmaceutical agents for epidermis; Sanitary sterilising preparations; Medicines for the treatment of gastrointestinal diseases; medicated mouth treatment preparations; Parasiticides for medical use; Diagnostic preparations for medical or veterinary purposes; Cleansing solutions for medical use; Cardiovascular agents for medical purposes; Reagents for medical use; Reagents for use in medical genetic testing; Hemostatics for medical purposes; Antibacterial substances for medical purposes; Diuretics; Insulin; Human vaccine preparations; General anesthetics; Pharmaceutical preparations for the treatment of auto-immune diseases; Multivitamin preparations; Pharmaceutical preparations acting on the central nervous system; Styptic pencils; Pharmaceutical preparations for treating asthma; Pharmaceutical solutions used in dialysis; Penicillin preparations; Antimicrobials for dermatologic use; Pharmaceutical preparations for treating skin disorders; Contraceptive preparations; Antihypertensives; Anti-diabetic pharmaceuticals; Antitoxins; Antivirals; Antiarrhythmic agents; Antibiotic preparations; Anti-cancer preparations; Anticoagulants; Tumor suppressing agents; Antifungal preparations; Anti-dermoinfectives; Antidotes; Antipyretic analgesics; Vasoconstrictors; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Mixed antibiotic preparations; Mixed hormone preparations; Chemotherapeutics; Pharmaceutical preparations for use in discouraging the smoking habit

Class 35

Retail and wholesale store services for pharmaceuticalveterinary and sanitary preparations and medical supplies; advertising services relating to pharmaceutical products; advertising relating to pharmaceutical products and in-vivo imaging products

Publications

History of USPTO decisions and trademark events.

47 publications found

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

08/06/2026

INNA

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

07/20/2026

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

07/16/2026

INPC

INVALIDATION PROCESSED

07/16/2026

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

12/26/2025

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

12/22/2025

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

04/26/2025

71AG

REGISTERED-SEC.71 ACCEPTED

04/26/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/21/2025

ES71

TEAS SECTION 71 RECEIVED

12/05/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/06/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/06/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/06/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

06/06/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

06/06/2024

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

12/04/2023

CHLD

CHANGE OF OWNER RECEIVED FROM IB

09/22/2023

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

04/05/2019

FICS

FINAL DISPOSITION NOTICE SENT TO IB

03/15/2019

FIMP

FINAL DISPOSITION PROCESSED

03/15/2019

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

03/04/2019

LIMN

LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED

12/04/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

12/04/2018

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

11/30/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/18/2018

PUBO

PUBLISHED FOR OPPOSITION

09/18/2018

GPNX

NOTIFICATION PROCESSED BY IB

09/15/2018

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

08/29/2018

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

08/29/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/29/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/10/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/20/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/20/2018

ALIE

ASSIGNED TO LIE

07/20/2018

ALIE

ASSIGNED TO LIE

07/18/2018

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/06/2018

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/06/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/06/2018

RFNT

REFUSAL PROCESSED BY IB

02/10/2018

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

01/20/2018

RFRR

REFUSAL PROCESSED BY MPU

01/20/2018

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

01/10/2018

CNRT

NON-FINAL ACTION WRITTEN

01/09/2018

DOCK

ASSIGNED TO EXAMINER

01/08/2018

MAFR

APPLICATION FILING RECEIPT MAILED

12/09/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/05/2017

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/23/2017

Continuous trademark protection

Get notified about every new filing that threatens CUREVO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.